Delivery Order SPE2DR25D3101-SPE2DR26F5P76
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract valued at $7,349.03. The award, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location, leveraging its...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.40 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count) on November 26, 2025, with completion due by November 28, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating open competition among qualified pharmaceutical distributors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $27,246.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on November 10, 2025, with an ultimate completion date of November 12, 2025. The award was made competitively with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a $37,071.79 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Gemtesa 75 mg tablets (90-count units), with completion scheduled for October 30, 2025. The contract employs firm fixed pricing with no small business set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $22,982.71 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on August 29, 2025, with a completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,159.12 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on November 8, 2025, with completion scheduled for November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $14,891.75 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price contract is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,822.11 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $29,726.93 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $46,560.49 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed price contract. This non-competitive delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor supporting federal medical procurement. The place of performance is located at the...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5P76Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,747.75 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed price delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a prime indefinite delivery vehicle valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The contract demonstrates AmerisourceBergen Drug Corp's capability to fulfill federal medical supply requirements across multiple therapeutic domains through competitive acquisition processes and flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 11/24/25 |